By Admin at 23 Oct 2017
At a meeting of the American Association of Cancer Research in Boston, Dr. Steven Rosenberg, researcher and chief of surgery at the National Cancer Institute (NCI) reported on the first patient with metastatic breast cancer to be essentially cured following immunotherapy treatment.
By Admin at 30 Mar 2017
Part of the challenge of winning the war against cancer lies in treating the disease in its later stages — a point at which many cancers become hard, if not impossible, to eliminate. Cancer interception may change that by targeting cancer at its earliest stages, in some cases even before it starts.
By Admin at 12 Jan 2017
A Gateway-funded clinical trial is making big news for breakthrough success in brain cancer. For the first time, researchers have successfully used a form of immunotherapy, which harnesses a patient’s own immune system to fight cancer, to treat an aggressive type of brain tumor called glioblastoma.
By Admin at 22 Aug 2016
Certain types of immunotherapy drugs have been making significant impacts on cancer treatments since 2011, and five years later they are still a large force in making aggressive and hard-to-treat cancers beatable.
By Admin at 13 Jul 2016
A new study showed that incorporating immunotherapy into ovarian cancer treatment might combat chemotherapy resistance and improve survival rates.
58
Current Gateway-funded clinical trials
150+
Clinical trials funded at leading institutions worldwide
$16.56
Funds one patient for one day at a Gateway-funded clinical trial